Deals
Myomo Deal Team Discusses Execution Strategy
|
The Regulation A deal team of medical device company Myomo (MYO), told a packed room last week at the Marcum Microcap conference in New York City that institutional investor thought their new mini-IPO deal wouldn’t trade in the secondary market so they wouldn’t invest.